Item Details

FDA's Generic Drug Enforcement and Approval Process [electronic resource]: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, First Session, March 7 and June 5, 1991

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O., 1992.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.En 2/3:102-77
Description
iii, 587 p. : ill. ; 24 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1991-HEC-0068
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
  • Includes bibliographical references.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details

  • LEADER 02909nam a22003731a 4500
    001 cis2007459934
    006 m d f
    007 cr bn mmmapmmp
    008 091022s1992 dcua sb f000 0 eng d
    043
      
      
    a| n-us---
    074
      
      
    a| 1019-A, 1019-B (MF)
    086
    0
      
    a| Y 4.En 2/3:102-77
    088
      
      
    a| Serial no. 102-77 (United States. Congress. House. Committee on Energy and Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Oversight and Investigations.
    245
    1
    0
    a| FDA's generic drug enforcement and approval process h| [electronic resource] : b| hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1992.
    300
      
      
    a| iii, 587 p. : b| ill. ; c| 24 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1991-HEC-0068
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    504
      
      
    a| Includes bibliographical references.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    0
    a| Pharmaceutical industry z| United States x| Corrupt practices.
    650
      
    0
    a| Pharmaceutical industry z| United States x| Quality control.
    650
      
    0
    a| Generic drugs z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations t| FDA's generic drug enforcement and approval process w| (DGPO)92069019 w| (OCoLC)25422136
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations t| FDA's generic drug enforcement and approval process. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 92 H361-50 w| (ProQuest)cis09200679
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1991-HEC-0068 y| Electronic resource (PDF)
    998
      
      
    a| cis09200679
    040
      
      
    a| UMI c| UMI

Availability

Read Online